AKT1 and Parkinson disease: It seems that the increase in the level of miR-149-5p after the injection of CJ-MSCs inhibits the Akt/mTOR pathway, clearing the accumulated intracellular α-Syand by increasing autophagy, thus improving the motor outcomes of PD.